Management of Fractures and Failures Around Tumor Implants

  • Roberto CasadeiEmail author
  • Gabriele Drago
  • Davide Donati


As more patients with skeletal metastases live longer, many implants are at risk for mechanical failure and for tumor progression in the face of previous treatment. The causes for and treatment options available to failed cases have received some attention in the literature, but few papers suggested what surgery was the best. Failures around tumor implants can be mechanical and not mechanical. The first include dislocation, soft tissue defect, wound dehiscence, aseptic loosening, and fractures, whereas the second infections and disease progression. For all types of failure, different strategies of treatment are described.


Complications Mechanical failures Infections Disease Progression 



Each author certified that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.


  1. 1.
    Laitinen M, Parry M, Ratasvuori M, Wedin R, Albergo JI, Jeys L, et al. Survival and complications of skeletal reconstructions after surgical treatment of bony metastatic renal cell carcinoma. Eur J Surg Oncol. 2015;41(7):886–92.CrossRefPubMedGoogle Scholar
  2. 2.
    Guzik G. Results of the treatment of bone metastases with modular prosthetic replacement—analysis of 67 patients. J Orthop Surg. 2016;11:20.CrossRefGoogle Scholar
  3. 3.
    Sørensen MS, Gregersen KG, Grum-Schwensen T, Hovgaard D, Petersen MM. Patient and implant survival following joint replacement because of metastatic bone disease. Acta Orthop. 2013;84(3):301–6.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Forsberg JA, Wedin R, Bauer H. Which implant is best after failed treatment for pathologic femur fractures? Clin Orthop. 2013;471(3):735–40.CrossRefPubMedGoogle Scholar
  5. 5.
    Henrichs M-P, Krebs J, Gosheger G, Streitbuerger A, Nottrott M, Sauer T, et al. Modular tumor endoprostheses in surgical palliation of long-bone metastases: a reduction in tumor burden and a durable reconstruction. World J Surg Oncol. 2014;12:330.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Tanaka T, Imanishi J, Charoenlap C, Choong PFM. Intramedullary nailing has sufficient durability for metastatic femoral fractures. World J Surg Oncol. 2016;14:80.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Henderson ER, Groundland JS, Pala E, Dennis JA, Wooten R, Cheong D, et al. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am. 2011;93(5):418–29.CrossRefPubMedGoogle Scholar
  8. 8.
    Wedin R, Hansen BH, Laitinen M, Trovik C, Zaikova O, Bergh P, et al. Complications and survival after surgical treatment of 214 metastatic lesions of the humerus. J Shoulder Elbow Surg. 2012;21(8):1049–55.CrossRefPubMedGoogle Scholar
  9. 9.
    Capanna R, Scoccianti G, Frenos F, Vilardi A, Beltrami G, Campanacci DA. What was the survival of megaprostheses in lower limb reconstructions after tumor resections? Clin Orthop. 2015;473(3):820–30.CrossRefPubMedGoogle Scholar
  10. 10.
    Pala E, Henderson ER, Calabrò T, Angelini A, Abati CN, Trovarelli G, et al. Survival of current production tumor endoprostheses: complications, functional results, and a comparative statistical analysis. J Surg Oncol. 2013;108(6):403–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Steensma M, Boland PJ, Morris CD, Athanasian E, Healey JH. Endoprosthetic treatment is more durable for pathologic proximal femur fractures. Clin Orthop. 2012;470(3):920–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Laitinen M, Nieminen J, Pakarinen T-K. Treatment of pathological humerus shaft fractures with intramedullary nails with or without cement fixation. Arch Orthop Trauma Surg. 2011;131(4):503–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Kostuj T, Streit R, Baums MH, Schaper K, Meurer A. Midterm outcome after mega-prosthesis implanted in patients with bony defects in cases of revision compared to patients with malignant tumors. J Arthroplast. 2015;30(9):1592–6.CrossRefGoogle Scholar
  14. 14.
    Thambapillary S, Dimitriou R, Makridis KG, Fragkakis EM, Bobak P, Giannoudis PV. Implant longevity, complications and functional outcome following proximal femoral arthroplasty for musculoskeletal tumors: a systematic review. J Arthroplast. 2013;28(8):1381–5.CrossRefGoogle Scholar
  15. 15.
    Alvi HM, Damron TA. Prophylactic stabilization for bone metastases, myeloma, or lymphoma: do we need to protect the entire bone? Clin Orthop. 2013;471(3):706–14.CrossRefPubMedGoogle Scholar
  16. 16.
    Wedin R, Bauer HCF. Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? J Bone Joint Surg Br. 2005;87(12):1653–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Shehadeh A, Noveau J, Malawer M, Henshaw R. Late complications and survival of endoprosthetic reconstruction after resection of bone tumors. Clin Orthop. 2010;468(11):2885–95.CrossRefPubMedGoogle Scholar
  18. 18.
    Hettwer WH, Horstmann PF, Hovgaard TB, Grum-Scwensen TA, Petersen MM. Low infection rate after tumor hip arthroplasty for metastatic bone disease in a cohort treated with extended antibiotic prophylaxis. Adv Orthop. 2015;2015:428986.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Jacofsky DJ, Haidukewych GJ, Zhang H, Sim FH. Complications and results of arthroplasty for salvage of failed treatment of malignant pathologic fractures of the hip. Clin Orthop. 2004;427:52–6.CrossRefGoogle Scholar
  20. 20.
    Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Barut N, Anract P, Babinet A, Biau D. Peri-prosthetic fractures around tumor endoprostheses: a retrospective analysis of eighteen cases. Int Orthop. 2015;39(9):1851–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Capanna R, Campanacci DA. The treatment of metastases in the appendicular skeleton. J Bone Joint Surg Br. 2001;83(4):471–81.CrossRefPubMedGoogle Scholar
  23. 23.
    Fakler JK, Hase F, Böhme J, Josten C. Safety aspects in surgical treatment of pathological fractures of the proximal femur—modular endoprosthetic replacement vs. intramedullary nailing. Patient Saf Surg. 2013;7(1):37.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Menendez LR, Ahlmann ER, Kermani C, Gotha H. Endoprosthetic reconstruction for neoplasms of the proximal femur. Clin Orthop. 2006;450:46–51.CrossRefPubMedGoogle Scholar
  25. 25.
    Houdek MT, Wagner ER, Wilke BK, Wyles CC, Taunton MJ, Sim FH. Long term outcomes of cemented endoprosthetic reconstruction for periarticular tumors of the distal femur. Knee. 2016;23(1):167–72.CrossRefPubMedGoogle Scholar
  26. 26.
    Hobusch GM, Funovics PT, Hourscht C, Domayer SE, Puchner SE, Dominkus M, et al. LARS® band and tube for extensor mechanism reconstructions in proximal tibial modular endoprostheses after bone tumors. Knee. 2016;23(5):905–10.CrossRefPubMedGoogle Scholar
  27. 27.
    Stavropoulos NA, Sawan H, Dandachli F, Turcotte RE. Use of ligament advanced reinforcement system tube in stabilization of proximal humeral endoprostheses. World J Orthop. 2016;7(4):265–71.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Houdek MT, Wagner ER, Wilke BK, Wyles CC, Taunton MJ, Sim FH. Late complications and long-term outcomes following aseptic revision of a hip arthroplasty performed for oncological resection. Hip Int. 2015;25(5):428–34.CrossRefPubMedGoogle Scholar
  29. 29.
    Bickels J, Kollender Y, Wittig JC, Cohen N, Meller I, Malawer MM. Vacuum-assisted wound closure after resection of musculoskeletal tumors. Clin Orthop. 2005;441:346–50.CrossRefPubMedGoogle Scholar
  30. 30.
    Healey JH, Morris CD, Athanasian EA, Boland PJ. Compress knee arthroplasty has 80% 10-year survivorship and novel forms of bone failure. Clin Orthop. 2013;471(3):774–83.CrossRefPubMedGoogle Scholar
  31. 31.
    Gebhart M, Shumelinsky F. Management of periprosthetic fractures in patients treated with a megaprosthesis for malignant bone tumours around the knee. Acta Orthop Belg. 2012;78(4):558–63.PubMedGoogle Scholar
  32. 32.
    Wright TW, Cofield RH. Humeral fractures after shoulder arthroplasty. J Bone Joint Surg Am. 1995;77(9):1340–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Piccioli A, Rossi B, Sacchetti FM, Spinelli MS, Di Martino A. Fractures in bone tumour prosthesis. Int Orthop. 2015;39(10):1981–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Worland RL, Kim DY, Arredondo J. Periprosthetic humeral fractures: management and classification. J Shoulder Elb Surg. 1999;8(6):590–4.CrossRefGoogle Scholar
  35. 35.
    Duncan CP, Haddad FS. The Unified Classification System (UCS): improving our understanding of periprosthetic fractures. Bone Joint J. 2014;96-B(6):713–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Bickels J, Kollender Y, Wittig JC, Meller I, Malawer MM. Function after resection of humeral metastases: analysis of 59 consecutive patients. Clin Orthop. 2005;437:201–8.CrossRefGoogle Scholar
  37. 37.
    Hardes J, Gebert C, Schwappach A, Ahrens H, Streitburger A, Winkelmann W, et al. Characteristics and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg. 2006;126(5):289–96.CrossRefPubMedGoogle Scholar
  38. 38.
    Hardes J, von Eiff C, Streitbuerger A, Balke M, Budny T, Henrichs MP, et al. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol. 2010;101(5):389–95.PubMedGoogle Scholar
  39. 39.
    Racano A, Pazionis T, Farrokhyar F, Deheshi B, Ghert M. High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review. Clin Orthop. 2013;471(6):2017–27.CrossRefPubMedGoogle Scholar
  40. 40.
    Lee SH, Kim HS, Park YB, Rhie TY, Lee HK. Prosthetic reconstruction for tumours of the distal tibia and fibula. J Bone Joint Surg Br. 1999;81(5):803–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Roberto Casadei
    • 1
    Email author
  • Gabriele Drago
    • 1
  • Davide Donati
    • 1
  1. 1.Department of Musculoskeletal OncologyIstituto Ortopedico RizzoliBolognaItaly

Personalised recommendations